Mohorn M, Knüpfer M
Z Gesamte Inn Med. 1984 Nov 1;39(21):527-30.
In 15 asthmatics (7 females, 8 males, average age 23.3 years) the efficacy of the calcium antagonist nifedipine (Corinfar) and of PAMBA on the exercise-induced asthma was investigated. The patients underwent for 6 minutes a submaximal exercise (80 +/- 5% of the age-related maximum pulse rate) on the bicycle ergometer or by free running. Nifedipine exhibited a highly significant inhibition of the exercise-induced bronchial obstruction (p less than 0.001). Under the PAMBA-medication no significant differences could be stated in comparison to the exercise test without medicament (p greater than 0.5). A standardization of the exercise tests is to be aspired to.
对15名哮喘患者(7名女性,8名男性,平均年龄23.3岁)研究了钙拮抗剂硝苯地平(硝苯心定)和止血芳酸对运动诱发性哮喘的疗效。患者在自行车测力计上或通过自由跑步进行6分钟的亚极量运动(与年龄相关的最大脉搏率的80±5%)。硝苯地平对运动诱发性支气管阻塞表现出高度显著的抑制作用(p<0.001)。与未用药的运动试验相比,在使用止血芳酸治疗时未发现显著差异(p>0.5)。应致力于运动试验的标准化。